Levothyroxine 200mcg Inj, 1 Vial
Overview
What is this medicine?
How to Use This Medicine
For storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to keep this medication at home.
If you miss a dose, contact your doctor immediately to receive guidance on the next steps to take.
Lifestyle & Tips
- For IV administration, no specific lifestyle changes are required related to food or other oral intake.
- Report any new or worsening symptoms to your healthcare provider immediately.
- Adhere to all monitoring appointments and blood tests as scheduled by your doctor.
Available Forms & Alternatives
Available Strengths:
- Levothyroxine 0.100mg(100mcg) Tab
- Levothyroxine 0.075mg (75mcg) Tabs
- Levothyroxine 0.125mg (125mcg) Tab
- Levothyroxine 0.05mg (50mcg) Tab
- Levothyroxine 0.025mg (25mcg) Tab
- Levothyroxine 0.112mg (112mcg) Tabs
- Levothyroxine 0.137mg (137mcg) Tab
- Levothyroxine 0.175mg (175mcg) Tabs
- Levothyroxine 500mcg Inj, 1 Vial
- Levothyroxine Sod 100mcg Inj, 1vial
- Levothyroxine 200mcg Inj, 1 Vial
- Levothyroxine 0.088mg (88mcg) Tab
- Levothyroxine 0.100mg (100mcg) Tab
- Levothyroxine 0.150mg (150mcg) Tab
- Levothyroxine 0.2mg (200mcg) Tab
- Levothyroxine 0.3mg (300mcg) Tab
- Levothyroxine 0.013mg (13mcg) Caps
- Levothyroxine 0.025mg (25mcg) Caps
- Levothyroxine 0.05mg (50mcg) Caps
- Levothyroxine 0.075mg (75mcg) Caps
- Levothyroxine 0.088mg (88mcg) Caps
- Levothyroxine 0.100mg (100mcg) Caps
- Levothyroxine 0.112mg (112mcg) Caps
- Levothyroxine 0.125mg (125mcg) Caps
- Levothyroxine 0.137mg (137mcg) Caps
- Levothyroxine 0.150mg (150mcg) Caps
- Levothyroxine 0.175mg (175mcg) Caps
- Levothyroxine 0.2mg (200mcg) Caps
- Levothyroxine 0.125mg (125mcg) Tabs
- Levothyroxine 100mcg/5ml Inj, 5ml
- Levothyroxine 100mcg/ml Inj, 1ml
- Levothyroxine 500mg/5ml Inj, 5ml
- Levothyroxine 200mcg/5ml Inj, 5ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Chest pain or pressure
Fast or abnormal heartbeat
Shortness of breath
Sudden weight gain or swelling in the arms or legs
Headache
Feeling tired or weak
Changes in appetite
Unintentional weight changes
Diarrhea, stomach cramps, or vomiting
Mood changes, such as feeling irritable, nervous, excitable, anxious, or restless
Shakiness
Trouble sleeping
Sensitivity to heat
Excessive sweating
Fever
Muscle cramps
Muscle weakness
Flushing
Bone pain
Changes in menstrual periods (in women)
In children: hip or knee pain, or a limp
In infants: changes in the shape of the head and face
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
* Hair loss (usually temporary and resolves on its own within the first few months of treatment)
Reporting Side Effects
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Chest pain
- Palpitations or rapid heart rate
- Shortness of breath
- Excessive sweating
- Tremors
- Nervousness or anxiety
- Insomnia
- Unexplained weight loss
- Severe headache
- Seizures
- Signs of adrenal crisis (severe weakness, dizziness, confusion, abdominal pain)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ An overactive thyroid gland
+ A weak adrenal gland
This list is not exhaustive, and it is crucial to discuss all your health problems and medications with your doctor.
To ensure your safety, provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
* Your health problems, both past and present
Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm it is safe to do so. This will help prevent potential interactions and ensure the safe use of this medication.
Precautions & Cautions
It is crucial that you inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. To ensure uninterrupted treatment, do not allow your supply of this medication to run out. You may not experience the full effects of this medication for several weeks.
If you have diabetes (high blood sugar), consult with your doctor, as this medication may affect your blood sugar control. Your doctor may need to adjust your diabetes medications. Be sure to monitor your blood sugar levels as directed by your doctor and undergo regular blood tests as recommended.
If you are taking biotin or a product containing biotin, stop taking it at least 2 days before having your thyroid levels checked to ensure accurate test results.
Potential Risks and Side Effects
High doses of this medication may increase the risk of developing weak bones (osteoporosis), particularly after menopause. Discuss your risk factors with your doctor, who can help determine if you are at higher risk or answer any questions you may have.
This medication may also affect fertility, potentially making it difficult to become pregnant or father a child. If you plan to conceive, consult with your doctor before starting this medication.
Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor, who will discuss the benefits and risks of this medication for both you and your baby.
Pediatric Patients
If your child is taking this medication and experiences any changes in weight, consult with your doctor, as the dosage may need to be adjusted. Never give your child more of this medication than prescribed, as this can increase the risk of severe side effects.
In some cases, this medication may affect growth in children and teenagers. Regular growth checks may be necessary, so be sure to discuss this with your doctor.
Overdose Information
Overdose Symptoms:
- Palpitations
- Tachycardia
- Arrhythmias
- Chest pain
- Tremors
- Nervousness
- Insomnia
- Excessive sweating
- Heat intolerance
- Weight loss
- Diarrhea
- Vomiting
- Fever
- Seizures (rare)
- Coma (rare)
What to Do:
Seek immediate medical attention. Management is symptomatic and supportive. May involve reducing absorption (if oral overdose), beta-blockers for cardiac symptoms, and other supportive care. Call 1-800-222-1222 for poison control.
Drug Interactions
Major Interactions
- Amiodarone (can cause hypo- or hyperthyroidism, alters T4 to T3 conversion)
- Antacids (aluminum, magnesium, calcium) - for oral form, but relevant if patient transitions to oral
- Iron supplements - for oral form, but relevant if patient transitions to oral
- Sucralfate - for oral form, but relevant if patient transitions to oral
- Bile acid sequestrants (cholestyramine, colestipol) - for oral form, but relevant if patient transitions to oral
- Proton pump inhibitors (e.g., omeprazole) - for oral form, may reduce absorption
- Certain anticonvulsants (e.g., carbamazepine, phenytoin, phenobarbital) - may increase levothyroxine metabolism
- Rifampin - may increase levothyroxine metabolism
- Sertraline - may increase levothyroxine requirements
- Tyrosine kinase inhibitors (e.g., imatinib, sunitinib) - may increase levothyroxine requirements
Moderate Interactions
- Oral anticoagulants (e.g., warfarin) - levothyroxine may enhance anticoagulant effect, requiring dose reduction of anticoagulant
- Beta-blockers (e.g., propranolol) - may reduce conversion of T4 to T3
- Tricyclic antidepressants (e.g., amitriptyline) - increased risk of cardiac arrhythmias and CNS excitation
- Insulin and oral hypoglycemics - levothyroxine may increase blood glucose, requiring adjustment of antidiabetic agents
- Digitalis glycosides (e.g., digoxin) - levothyroxine may decrease digoxin levels or effect
- Estrogens (oral) - may increase TBG, increasing levothyroxine requirements
- Androgens - may decrease TBG, decreasing levothyroxine requirements
Minor Interactions
- Dietary fiber - for oral form, may reduce absorption
- Soy products - for oral form, may reduce absorption
Monitoring
Baseline Monitoring
Rationale: To assess baseline thyroid function and confirm diagnosis of hypothyroidism.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline thyroid function and confirm diagnosis of hypothyroidism, especially in central hypothyroidism or myxedema coma.
Timing: Prior to initiation of therapy.
Rationale: To assess for underlying cardiovascular disease, especially important in myxedema coma due to risk of cardiac complications with rapid thyroid hormone replacement.
Timing: Prior to initiation and during initial treatment, particularly with IV loading doses.
Rationale: To rule out co-existing adrenal insufficiency, which must be treated with glucocorticoids before or concurrently with levothyroxine to avoid adrenal crisis.
Timing: Prior to initiation in patients with suspected myxedema coma or long-standing hypothyroidism.
Routine Monitoring
Frequency: Every 4-6 weeks after initiation or dose change, then every 6-12 months once stable.
Target: 0.4-4.0 mIU/L (individualized based on patient age, comorbidities, and specific condition).
Action Threshold: Adjust dose if TSH is outside target range; higher TSH indicates under-replacement, lower TSH indicates over-replacement.
Frequency: Every 4-6 weeks after initiation or dose change, then every 6-12 months once stable, or if TSH is suppressed/elevated.
Target: 0.8-1.8 ng/dL (or within upper half of reference range for primary hypothyroidism).
Action Threshold: Adjust dose if Free T4 is outside target range, especially in central hypothyroidism or when TSH is unreliable.
Frequency: Continuously, at each clinical visit.
Target: Resolution of hypothyroid symptoms, absence of hyperthyroid symptoms.
Action Threshold: Evaluate for dose adjustment or other causes if symptoms persist or new symptoms develop.
Frequency: Daily or more frequently in acute settings (e.g., myxedema coma), then at each clinical visit.
Target: Within normal limits for the patient.
Action Threshold: Tachycardia, palpitations, or hypertension may indicate over-replacement; bradycardia or hypotension may indicate under-replacement or other issues.
Symptom Monitoring
- Fatigue
- Weight gain or loss
- Cold or heat intolerance
- Constipation or diarrhea
- Dry skin
- Hair loss
- Muscle aches or weakness
- Depression or anxiety
- Memory problems
- Bradycardia or tachycardia
- Palpitations
- Tremors
- Nervousness
- Insomnia
Special Patient Groups
Pregnancy
Levothyroxine is considered safe and essential during pregnancy. Thyroid hormone requirements often increase during pregnancy, necessitating dose adjustments.
Trimester-Specific Risks:
Lactation
Levothyroxine is compatible with breastfeeding. Only small amounts are excreted into breast milk, which are not considered harmful to the infant.
Pediatric Use
Dosing is highly individualized based on age, weight, and severity of hypothyroidism. Close monitoring of TSH and Free T4 is essential. IV formulation is generally reserved for severe cases (e.g., myxedema coma) or when oral administration is not possible. Over-treatment can lead to craniosynostosis in infants and accelerated bone maturation in children.
Geriatric Use
Lower initial doses are generally recommended due to increased sensitivity to thyroid hormones and higher prevalence of underlying cardiovascular disease. Dose titration should be gradual and cautious, with close monitoring for cardiac side effects.
Clinical Information
Clinical Pearls
- IV levothyroxine is primarily used for myxedema coma or when oral administration is not feasible (e.g., NPO status, severe malabsorption).
- For myxedema coma, a large loading dose is typically given, followed by daily maintenance doses. Consider lower loading doses in patients with known cardiac disease.
- Always rule out or treat adrenal insufficiency with glucocorticoids before or concurrently with levothyroxine in patients with suspected myxedema coma to prevent adrenal crisis.
- The IV dose is typically 50% of the patient's usual oral dose when converting from oral to IV due to 100% bioavailability of the IV form.
- Monitor cardiac status closely, especially during the initial phase of treatment for myxedema coma, due to the risk of arrhythmias and myocardial ischemia.
- Thyroid function tests (TSH, Free T4) should be monitored regularly to guide dose adjustments, though TSH response may be delayed due to the long half-life.
Alternative Therapies
- Liothyronine (T3) injection (for rapid onset in severe cases, often used in combination with levothyroxine for myxedema coma)
- Desiccated thyroid extract (contains T4 and T3, not available in injectable form)